Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 26,251–26,275 of 27,380 studies, newest first · page 1051 of 1096.

January 1997 14

  1. 1997-01-01

    Limitations of the Mini-Mental State Examination in diagnosing dementia in general practice

    ✓ Peer-reviewed Cognitive tests and assessment International journal of geriatric psychiatry

    Key finding: The study population consisted of 533 elderly patients (aged 65 and older) judged by 36 GPs as suffering from 'minimal to severe' dementia. +3 more findings

  2. 1997-01-01
  3. 1997-01-01

    Increased low-level chromosome 21 mosaicism in older individuals with Down syndrome

    ✓ Peer-reviewed Down syndrome and Alzheimer's American journal of medical genetics

    Key finding: During a study of the familial aggregation of Down syndrome (DS) and Alzheimer disease (AD), we observed an increase in mosaicism for disomy 21 in older individuals with DS. +2 more findings

  4. 1997-01-01

    Aberrant expression of the constitutive endothelial nitric oxide synthase gene in Alzheimer disease

    ✓ Peer-reviewed Down syndrome and Alzheimer's Molecular and chemical neuropathology

    Key finding: The results suggest that aberrant ceNOS translocation and gene regulation may have important roles in the pathogenesis of AD neuritic pathology.

  5. 1997-01-01

    Prospective study of the prevalence of Alzheimer-type dementia in institutionalized individuals with Down syndrome

    ✓ Peer-reviewed Down syndrome and Alzheimer's American journal of mental retardation : AJMR

    Key finding: Progressive mental and physical deterioration was found for 56 of the residents. +4 more findings

  6. 1997-01-01

    Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm

    ✓ Peer-reviewed How common it is Neurology

    Key finding: (1) The incidence of dementia increases with age, even in the oldest age groups; (2) women have a higher risk of developing dementia than men, especially at very old ages; (3) this pattern is mainly due to the age and gender distribution of Alzheimer's disease, rather than vascular dementia. +1 more finding

  7. 1997-01-01

    Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study

    ✓ Peer-reviewed How common it is Lancet (London, England)

    Key finding: All indicators of atherosclerosis were associated with dementia (odds ratios ranging from 1.3 to 1.9) and its major subtypes Alzheimer's disease (odds ratios 1.3-1.8) and vascular dementia (odds ratios 1.9-3.2). +3 more findings

  8. 1997-01-01

    Criteria for Alzheimer's disease and the nosology of dementia with Lewy bodies

    ✓ Peer-reviewed Disparities Neurology

    Key finding: The percentages of mixed LB disease and AD versus pure LB disease varied from 91% mixed and 9% pure to 34% mixed and 66% pure, depending upon which diagnostic criteria for AD were employed.

  9. 1997-01-01

    Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease

    ✓ Peer-reviewed Caregiving Annals of neurology

    Key finding: These data suggest that neuronal loss in association areas such as the superior temporal sulcus contributes directly to cognitive impairment in AD.

  10. 1997-01-01

    Quantitative magnetic resonance imaging in geriatric depression and primary degenerative dementia

    ✓ Peer-reviewed Brain scans and imaging Journal of affective disorders

    Key finding: Compared to the controls, depressed patients showed a significantly lower whole brain volume and a significantly higher CSF volume, whereas volumes of the frontal and temporal lobes as well as the amygdala-hippocampus complex volumes were not significantly decreased. +2 more findings

  11. 1997-01-01

    Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study

    ✓ Peer-reviewed Getting a diagnosis Alzheimer disease and associated disorders

    Key finding: As part of an overall ADCS protocol to develop new instruments to be used in trials of treatments for Alzheimer's disease (AD), patients with mild to moderate AD and cognitively normal elderly were administered a battery of five tests at least three times over 1 year.

  12. 1997-01-01

    Aging, memory, and mild cognitive impairment

    ✓ Peer-reviewed Getting a diagnosis International psychogeriatrics

    Key finding: Our results and similar data from other study groups indicate that diagnostic criteria can be defined for patients who are likely to convert to AD; the natural history of these patients is becoming apparent, and variables that predict ultimate conversion can be defined.

  13. 1997-01-01

    Protocols to demonstrate slowing of Alzheimer disease progression. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. The Disease Progression Sub-Group

    ✓ Peer-reviewed Treatments Alzheimer disease and associated disorders

    Key finding: Two suggested clinical trial designs for assessing progression of Alzheimer disease are the randomized withdrawal design and the randomized start design. +2 more findings

  14. 1997-01-01

    Slowing the progression of Alzheimer disease: methodologic issues

    ✓ Peer-reviewed Treatments Alzheimer disease and associated disorders

    Key finding: The evidence to support a claim that a new drug will slow the progression of Alzheimer disease (AD) must derive from epistemologically valid research methods. +4 more findings

December 1996 11

  1. 1996-12-01

    Visual hallucinations associated with Parkinson disease

    ✓ Peer-reviewed Health systems and care delivery Archives of neurology

    Key finding: The phenomena of visual hallucinations associated with PD, while not fully explained, are unique enough to be of interest to all neurologists and neuroscientists. +4 more findings

  2. 1996-12-01

    Pick's disease: hyperphosphorylated tau protein segregates to the somatoaxonal compartment

    ✓ Peer-reviewed Drug development Acta neuropathologica

    Key finding: Our results indicate that tau proteins in Pick's disease and Alzheimer's disease share similar phosphorylated residues, with the exception of serine 262, which is phosphorylated in Alzheimer tangles but not in Pick bodies or neuritic profiles.

  3. 1996-12-01

    Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study

    ✓ Peer-reviewed Brain scans and imaging Brain : a journal of neurology

    Key finding: Seven at risk members of a familial Alzheimer's disease pedigree associated with the amyloid precursor protein 717 valine to glycine mutation underwent serial MR scanning and neuropsychological assessments over 3 years. +3 more findings

  4. 1996-12-01

    The profile of soluble amyloid beta protein in cultured cell media. Detection and quantification of amyloid beta protein and variants by immunoprecipitation-mass spectrometry

    ✓ Peer-reviewed Risk genes beyond APOE The Journal of biological chemistry

    Key finding: We used this method to examine the Abeta species in conditioned media of mouse neuroblastoma cells transfected with cDNAs encoding wild type or mutant human amyloid precursor protein. +4 more findings

  5. 1996-12-01

    The cognitive effects of recombinant interleukin-2 (rIL-2) therapy: a controlled clinical trial using computerised assessments

    ✓ Peer-reviewed Cognitive tests and assessment European journal of cancer (Oxford, England : 1990)

    Key finding: It has been suggested that patients undergoing treatment with recombinant interleukin-2 (rIL-2) may develop cognitive impairment. +4 more findings

  6. 1996-12-01

    Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging

    ✓ Peer-reviewed Hippocampus size on brain scans The American journal of psychiatry

    Key finding: NAA-relative signal intensity reductions in schizophrenia appear to be remarkably localized, involving primarily the hippocampal region and the dorsolateral prefrontal cortex, two regions implicated prominently in the pathophysiology of this disorder. +2 more findings

  7. 1996-12-01

    Magnetic resonance imaging study of hippocampal volume in chronic, combat-related posttraumatic stress disorder

    ✓ Peer-reviewed Hippocampus size on brain scans Biological psychiatry

    Key finding: This study used quantitative volumetric magnetic resonance imaging techniques to explore the neuroanatomic correlates of chronic, combat-related posttraumatic stress disorder (PTSD) in seven Vietnam veterans with PTSD compared with seven nonPTSD combat veterans and eight normal nonveterans. +4 more findings

  8. 1996-12-01

    Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation

    ✓ Peer-reviewed Risk genes beyond APOE Science (New York, N.Y.)

    Key finding: Transfection of antisense PS2 conferred protection against apoptosis induced by trophic withdrawal in nerve growth factor-differentiated or amyloid precursor protein-expressing PC12 cells. +3 more findings

  9. 1996-12-01

    Oxidative stress and the pathogenesis of Parkinson's disease

    ✓ Peer-reviewed Lewy body dementia Neurology

    Key finding: A loss of GSH is associated with incidental Lewy body disease and may represent the earliest biochemical marker of nigral cell loss. +1 more finding

  10. 1996-12-01

    The role of magnetic resonance imaging in the diagnosis of Alzheimer disease in adults with Down syndrome

    ✓ Peer-reviewed Down syndrome and Alzheimer's Archives of neurology

    Key finding: Magnetic resonance imaging is potentially a valuable tool in the diagnosis of Alzheimer disease in adults with Down syndrome, particularly in individuals for whom standard intellectual assessments are not possible. +1 more finding

  11. 1996-12-01

    Unusual clinical presentations of cortical-basal ganglionic degeneration

    ✓ Peer-reviewed Digital health tools Annals of neurology

    Key finding: It is therefore apparent that the histological changes of cortical-basal ganglionic degeneration result in a variety of clinical presentations depending on the topography of the lesions. +1 more finding

Browse the library by subject, with the full score breakdown →